Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS

NCT01626079 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

776

Enrollment

INDUSTRY

Sponsor class

Conditions

Mitral Regurgitation
Mitral Valve Regurgitation
Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects
Heart Failure

Interventions

DEVICE: MitraClip System

Sponsor

Abbott Medical Devices